• |
    LogoImage2-AUCD

    AUCD Community Inclusion

    AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

  • |
    LogoImage2-AUCD

    AUCD Maternal and Child Health Engagement

    AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

  • |
    LogoImage2-AUCD

    AUCD Public Health

    AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

  • |
    LogoImage2-AUCD

    AUCD Emerging Leaders Community

    AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.  

Donate

Product

Back to Results

LEND: Intravenous N-Acetylcysteine to prevent cisplatin-induced hearing loss in children: A nonrandomized controlled phase 1 trial

Center:
OR-Oregon Institute on Development & Disability, UCEDD/LEND
Fiscal Year:
2023
Contact Information:
Kristin Knight
[email protected]
503-494-2061
Product Description:
Phase 1 clinical trial to determine the optimal dose, safety, and efficacy of N-Acetylcysteine to prevent cisplatin-induced hearing loss in children.
Keyword(s):
hearing loss, cisplatin, ototoxicity, otoprotection, children
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals, Students
Alternative Format:
Electronic (disc, CD, 508 compliant web posting)
To Obtain Copies (URL or Email):
[email protected]
COVID-19 Related Data:
N/A
Footer-Logo-AUCD

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910

Copyright 2024 Association of University Centers on Disabilities

Subscribe to AUCD’s Newsletter

Copyright 2024 Association of University Centers on Disabilities